Akumin (Akumin) Valuation Rank

View and export this data going back to 2017. Start your Free Trial

What is Akumin Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Akumin Valuation Rank Related Terms

Thank you for viewing the detailed overview of Akumin's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Akumin (Akumin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Akumin Inc (OTCPK:AKUMQ) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

AKU:Canada

Address

8300 West Sunrise Boulevard, Plantation, FL, USA, 33322

Website

https://www.akumin.com

Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.

Executives

Ronald J. Bienias	officer: Chief Restructuring Officer	C/O AKUMIN INC.,, 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Stonepeak Gp Investors Holdings Manager Llc	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Upper Holdings Lp	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Holdings Lp	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Krishna Kumar	officer: See remarks	C/O AKUMIN INC., 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Lawrence Ross Sinclair	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
R. David Kretschmer	officer: See Remarks	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Murray Lee	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Scw Capital Management, Lp	10 percent owner	3131 TURTLE CREEK BLVD., SUITE 302, DALLAS TX 75219
Trinity Investment Group, Llc	10 percent owner	3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
Robert N. Cathey	10 percent owner	3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
John R. Wagner	10 percent owner	3838 OAK LAWN AVE., SUITE 450, DALLAS TX 75219
Paul Nelis	officer: Chief Information Officer	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Haichen Huang	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Matt Cameron	officer: See Remarks	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322